24 HR Tacrolimus 1 MG Extended Release Oral Tablet [Envarsus]

Known as: 24 HR Envarsus 1 MG Extended Release Oral Tablet, Envarsus XR 1 MG 24HR Extended Release Oral Tablet, TACROLIMUS 1 mg ORAL TABLET, EXTENDED RELEASE [Envarsus XR]

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.

2018

Pharmacokinetics of Prolonged-Release Once-Daily Formulations of Tacrolimus in De Novo Kidney Transplant Recipients: A Randomized, Parallel-Group, Open-Label, Multicenter Study

N. Kamar, É. Cassuto, L. Rostaing
Advances in Therapy
2018
Corpus ID: 54632825

IntroductionDifferent prolonged-release formulations of tacrolimus are available. To date, the pharmacokinetic (PK) profile of…

2017

Population Pharmacokinetics and Bayesian Estimators for Refined Dose Adjustment of a New Tacrolimus Formulation in Kidney and Liver Transplant Patients

J. Woillard, J. Debord, C. Monchaud, F. Saint‐Marcoux, P. Marquet
Clinical Pharmacokinetics
2017
Corpus ID: 19765895

Background and ObjectivesA new once-daily formulation of tacrolimus (Envarsus®) has recently been developed, with alleged…

24 HR Tacrolimus 1 MG Extended Release Oral Tablet [Envarsus]

Related topics

Broader (1)

Papers overview